(Q37019565)

17 August 2017

Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial (English)

1 reference

17 August 2017

1 reference

5

Julie E Buring

1 reference

17 August 2017

1

Nancy R Cook

1 reference

17 August 2017

I-Min Lee

2

1 reference

17 August 2017

Shumin M Zhang

series ordinal

3

1 reference

17 August 2017

M Vinayaga Moorthy

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

Annals of Internal Medicine

17 August 2017

1 reference

17 August 2017

159

1 reference

17 August 2017

2

1 reference

17 August 2017

77-85

1 reference

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin and cancer risk: a quantitative review to 2011.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

The role of aspirin in cancer prevention

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Are we ready to recommend aspirin for cancer prevention?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Platelet-active drugs : the relationships among dose, effectiveness, and side effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

The performance of different propensity score methods for estimating marginal hazard ratios

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3713531

Baseline Characteristics of Participants in the Women's Health Study

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23856681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Beyond willow bark: aspirin in the prevention of chronic disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23856681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7326/0003-4819-159-2-201307160-00002

1 reference

17 August 2017

1 reference

17 August 2017

1 reference